Distinct changes to pancreatic volume rather than pancreatic autoantibody positivity: insights into immune checkpoint inhibitors induced diabetes mellitus.

Authors:
Wei HH; Lai YC; Lin G; Lin CW; Chang YC and 3 more

Journal:
Diabetol Metab Syndr

Publication Year: 2024

DOI:
10.1186/s13098-024-01263-6

PMCID:
PMC10804587

PMID:
38254155

Journal Information

Full Title: Diabetol Metab Syndr

Abbreviation: Diabetol Metab Syndr

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Endocrinology & Metabolism

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThis study was approved by the institutional review board (IRB) of CGMH (202201766B0). The consent to participate was not required because of retrospective entity of this study which was approved by IRB of CGMH. Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

Evidence found in paper:

"Funding This work was supported by grants from Linkou Chang-Gung Memorial Hospital (CLRPG3K0024, CMRPG3M0732, CMRPG3J1291 ~ 2) and National Science and Technology Council, Taiwan (NSTC 110-2628-B-182A). The funders had no role in the study design, data collection, analysis and interpretation, preparation of the manuscript and the decision to publish the results."

Evidence found in paper:

"Trial registration Not applicable."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025